Loading...

Established in 2023, this laboratory boasts a strong reputation and the potential for scalable growth. It serves a diverse range of healthcare facilities, including hospitals, specialty clinics, and primary care practices. With new accounts added every 10 days, the lab predominantly operates on a cash (client-billed) model, ensuring a steady revenue stream.
The laboratory's comprehensive departments include Clinical Chemistry, Special Chemistry, Immunology, Hematology, Coagulation, and Molecular Diagnostics, offering a broad spectrum of diagnostic services. This turnkey investment is ideally suited for healthcare entrepreneurs or investors seeking high returns in the medical diagnostics sector.
Due to seller confidentiality, detailed balance sheets, customer concentration, tax returns, and supplier agreements require executing our digital bilateral NDA.
Free for qualified buyers & acquisition searchers.
Calculate fair market enterprise value and compare EBITDA multiples against industry benchmarks.
Launch Valuation Calculator